Addressing Hyperglycemia in Type 2 Diabetes (T2D) Patients with Moderate-to-Severe Chronic Kidney Disease

Once-weekly dulaglutide compared with daily insulin glargine as basal therapy, both in combination with insulin lispro1 Despite increasing awareness and new developments in the treatment and prevention of diabetes, there has been a rapid increase in the number of people with T2D.² Tight glycemic control may reduce the risk of diabetes complications in people with Read More …